AI assistant
Wave Life Sciences Ltd. — Director's Dealing 2020
Jul 3, 2020
31900_dirs_2020-07-02_2793d69d-a6ec-40f2-8b56-bb0614876d36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2020-07-02
Reporting Person: BOLNO PAUL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-02 | Ordinary Shares | S | 4509 | $10.82 | Disposed | 315249 | Direct |
| 2020-07-02 | Ordinary Shares | S | 43068 | $10.26 | Disposed | 272181 | Direct |
| 2020-07-02 | Ordinary Shares | M | 100000 | $2.48 | Acquired | 372181 | Direct |
| 2020-07-02 | Ordinary Shares | S | 4079 | $10.91 | Disposed | 368102 | Direct |
| 2020-07-02 | Ordinary Shares | S | 95921 | $10.27 | Disposed | 272181 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-02 | Share Option (right to buy) | $2.48 | M | 100000 | Disposed | 2025-03-10 | Ordinary Shares (100000) | Direct |
Footnotes
F1: Consists of the sale of shares that were issued upon the vesting of restricted share units. The sale was effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.78 to $11.12 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $9.77 to $10.77 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F4: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F5: These share options are fully vested.